Evidence map›Paper›PMID 42583562›Full record

ArticleACS catalysis2026

Recognition of a Conserved Minimal Catalaphile Explains Catalyst Generality in Enantioselective Nitroalkene Reductions.

Zihang Deng, Julius E L Jan, Melanie A Padalino, Roxanne Dekeyser, Travis Dudding, Jeffrey N Johnston

Abstract read
In one paragraph

Article in ACS catalysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zihang DengDepartment of Chemistry and Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee 37235, USA.ORCID 0000-0002-5377-7484
Julius E L JanDepartment of Chemistry and Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee 37235, USA.
Melanie A PadalinoDepartment of Chemistry and Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee 37235, USA.ORCID 0000-0001-8936-5468
Roxanne DekeyserDepartment of Chemistry, Brock University, St. Catharines, ON L2S 3A1, Canada.
Travis DuddingDepartment of Chemistry, Brock University, St. Catharines, ON L2S 3A1, Canada.ORCID 0000-0002-2239-0818
Jeffrey N JohnstonDepartment of Chemistry and Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee 37235, USA.ORCID 0000-0002-0885-636X

Funding

Chemistry-Biology Interface Training GrantT32GM065086 · NIGMS · VANDERBILT UNIVERSITY · PI BACHMANN, BRIAN O, SULIKOWSKI, GARY ALLEN · 2002 to 2022
$7.0M
Studies in Amide and Peptide SynthesisR01GM063557 · NIGMS · VANDERBILT UNIVERSITY · PI JOHNSTON, JEFFREY NICHOLAS · 2002 to 2022
$4.5M
New Methods for Therapeutic DevelopmentR35GM156307 · NIGMS · VANDERBILT UNIVERSITY · PI Jeffrey Nicholas Johnston · 2025 to 2026
$845k
Application of New Amination Reactions to Natural Product and Nonnatural HeterocyR56GM063557 · NIGMS · VANDERBILT UNIVERSITY · PI JOHNSTON, JEFFREY NICHOLAS · 2008 to 2008
$292k
NIGMS NIH HHS R01 GM063557NIGMS NIH HHS R35 GM156307NIGMS NIH HHS R56 GM063557NIGMS NIH HHS T32 GM065086
6 · The paper itself

Abstract

In catalyst development for asymmetric synthesis, generality is most often an aspirational goal rather than a reality, driven by the direct relationship between catalyst utility and product access. Strategies and tools have been developed to prospect and identify catalyst generality, but the mechanistic underpinnings for generality remain unclear. Here we investigate the selectivity-generality paradox for chiral Amidine Amide (AmA) catalyzed nitroalkene reductions, identifying the origin of generality using both experimental and computational approaches. Use of an Independent Gradient Model (IGMH) and Non-Covalent Interaction maps (NCImaps) reveal a stark contrast in recognition modes: while limited-scope catalysts rely on adaptive Van der Waals interactions that vary with substrate structure, the general AmA catalyst utilizes a conserved hydrogen-bonding network that recognizes the nitroethylene moiety-the minimal catalaphile. This understanding provides a framework for elucidating how early development focused on generality can be propagated through rational design, supported by computation, and translated to the broadest possible application. We posit that the minimal catalaphile concept, and its prioritization in development, could be a coalescing principle in hypothesis-driven development of privileged catalysts.

Indexed as

Amidine Amide (AmA)catalyst generalitycon-covalent interaction (NCI) mappingminimal catalaphilenitroalkene reduction

Identifiers

PMID42583562
PMCPMC13461239

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.